| Status | In progress |
| Decision | Selected |
| Process | MT |
| ID number | 564 |
Provisional Schedule
| Draft guidance: 1 | 15 June 2022 - 13 July 2022 |
| Resolution | 05 September 2022 |
| Expected publication | 14 October 2022 |
Project Team
| Project lead | Samantha Baskerville |
Email enquiries
- If you have any queries please email MedTech@nice.org.uk
Stakeholders
| External assessment group | NUTH |
| Manufacturers | Boston Scientific |
| Others | Association of British Healthcare Industries (ABHI) |
| Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM) | |
| Boston Scientific | |
| Department of Health and Social Care | |
| Devices for Dignity | |
| Greater Manchester Health & Social Care Partnership | |
| Health Technology Wales | |
| Healthcare Improvement Scotland | |
| HealthTech Alliance | |
| Johnson & Johnson Medical Ltd | |
| Medical Technology Group | |
| Medicines and Healthcare Products Regulatory Agency | |
| University of Manchester Wounds Research Group | |
| NHS England | |
| The British In Vitro Diagnostics Association (BIVDA) | |
| NHS Digital |
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 20 May 2022 | Committee meeting: 1 |
| 22 October 2021 | Scope published |
| 04 October 2021 | Stakeholder registration opens |
For further information on our processes and methods, please see our CHTE processes and methods manual